Sporotrichoid Cutaneous Leishmaniasis in Central Iran
نویسنده
چکیده مقاله:
More than 90% of patients infected with cutaneous leishmaniasis live in Afghanistan, the Middle East, Algeria, Brazil, and Peru. Cutaneous leishmaniasis in Iran is caused by Leishmania tropica and Leishmania major. Most skin lesions evolve from papular to nodular, to ulcerative form with a central depression surrounded by a raised indurate border. Some lesions persist as nodules or plaques. Multiple primary lesions, satellite lesion, regional adenopathy and sporotrichoid subcutaneous nodules are variably present. This report presents an 18-yr-old man with sporotrichoid cutaneous leishmaniasis that is not common in the centralIran.Iran J Med Sci 2006; 31(3): 173-175. Keywords ● Sporotrichoid ● cutaneous ● leishmaniasis ●Iran
منابع مشابه
sporotrichoid cutaneous leishmaniasis in central iran
more than 90% of patients infected with cutaneous leishmaniasis live in afghanistan, the middle east, algeria, brazil, and peru. cutaneous leishmaniasis in iran is caused by leishmania tropica and leishmania major . most skin lesions evolve from papular to nodular, to ulcerative form with a central depression surrounded by a raised indurate border. some lesions persist as nodules or plaques. mu...
متن کامل[Sporotrichoid cutaneous leishmaniasis].
M López-Escobar, M Drake-Monfort, R Salesa-Gutiérrez de Rozas, and S Hermana-Ramírez Servicio de Dermatología, Servicio de Microbiología, and Servicio de Anatomía Patológica, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain white card. We selected the macro function in the digital camera, switched off the flash, and turned on the polarized light of the dermatoscope. We ...
متن کاملEpidemiological aspects and therapeutic outcomes of cutaneous leishmaniasis patients in Central Iran
Background & Aims of the Study: Cutaneous leishmaniasis (CL) is one of the re-emerging diseases in many areas of the Eastern Mediterranean region such as Iran. This study was conducted in order to detect the epidemiological aspects and therapeutic outcomes of CL patients in Kahakcounty, Qom province of Iran. Materials & Methods: In this cross sectional study, clinical diagno...
متن کاملRodenticide Comparative Effect of Klerat® and Zinc Phosphide for Controlling Zoonotic Cutaneous Leishmaniasis in Central Iran
BACKGROUND Zoonotic cutaneous leishmaniasis (ZCL) is a neglected disease with public health importance that is common in many rural areas of Iran. In recent years, behavioral resistance and/or bait shyness against the common rodenticide among reservoir hosts of ZCL have been reported. The aim of this study was to evaluate the effectiveness of Klerat® and zinc phosphide against natural reservoir...
متن کاملEpidemiological Aspects of Cutaneous Leishmaniasis during 2009–2016 in Kashan City, Central Iran
Cutaneous leishmaniasis (CL) can be seen in 2 forms, zoonotic and anthroponotic, in Iran. In this study, epidemiological aspects of CL were studied during an 8-year period (2009-2016) in city of Kashan, central Iran. The demographic and epidemiological data, including age, sex, occupation, number and site of the lesions, treatment regimen, past history of CL, and season of all patients were gat...
متن کاملThe changing profile of cutaneous leishmaniasis agent in a central province of Iran.
Cutaneous leishmaniasis in Iran is usually caused by Leishmania major or L. tropica. However, the direct examination or the cultures of biopsies for diagnosis are not very sensitive. The objective of this study was to identify the responsible species obtained from patients suspected of cutaneous leishmaniasis referred to the reference laboratory atYazd in Iran during 2010-2011 using parasitolog...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ذخیره در منابع من قبلا به منابع من ذحیره شده{@ msg_add @}
عنوان ژورنال
دوره 31 شماره 3
صفحات -
تاریخ انتشار 2006-09-01
با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023